13 | $BDTX ML4.56 MH5.88 f51.717M holding 20dma opens | znewcar1 | 04/17/2024 9:06:26 AM |
12 | BDTX Hod5.4 MH5.88=Major R view from the weekly | znewcar1 | 04/16/2024 3:38:55 PM |
11 | BDTX Friday pop?4.4 | znewcar1 | 02/02/2024 3:59:46 PM |
10 | $BDTX Lod4.51 H4.88 | znewcar1 | 07/05/2023 3:05:25 PM |
9 | $BDTX 235% v187,2M 6.18 36,512,572 +235.33% 6.85 | znewcar1 | 06/27/2023 4:07:00 PM |
8 | $BDTX Hod6.76 is that it? or can it squeeze | znewcar1 | 06/27/2023 1:35:13 PM |
7 | No pull back! Hod6.22 | znewcar1 | 06/27/2023 12:47:43 PM |
6 | expect a pull back yet push towards | znewcar1 | 06/27/2023 12:33:05 PM |
5 | BOOM! Hod5.5 | znewcar1 | 06/27/2023 12:32:00 PM |
4 | $BDTX BO4 to Hod4.47 next stop | znewcar1 | 06/27/2023 12:04:41 PM |
3 | $BDTX nice push towards 4 | znewcar1 | 06/27/2023 11:21:06 AM |
2 | $BDTX Lod3.19 with a few topping tails with (1) | znewcar1 | 06/27/2023 10:20:24 AM |
1 | BDTX Hod4.25 PMH4.59 holding @3.2 this could get | znewcar1 | 06/27/2023 10:16:16 AM |
Recent Articles
- Discover THREE's Innovative Skincare Breakthroughs Today!
- Novo Nordisk's Strategic Acquisition of Catalent's Manufacturing Assets
- Catalent and Novo Holdings Set to Finalize Major Deal Soon
- Opportunity for Wolfspeed Investors to Pursue Class Action
- Kyverna Therapeutics Investors Alert Over Recent Class Action
- Marqeta Inc. SEC Class Action Lawsuit: What Investors Need to Know
- Urgent Alert for Symbotic Investors Regarding Class Action
- Investors Reminded of Key Deadline in PACS Group Lawsuits
- Crucial Update for Five9 Investors: Lawsuit Deadline Approaching
- Important Update for Rentokil Investors on Class Action Lawsuit
- Important Update for Match Group Investors: Legal Actions Ahead
- Investors Urged to Act in Zeta Global Class Action Case
- Celsius Holdings Investors: Important Litigation Updates
- ASML Holding Class Action: Important Update for Investors
- Deadline Approaches for Hasbro Shareholders in Class Action
- Critical Update for Toronto-Dominion Bank Investors in Class Action
- Investors of Kyverna Therapeutics Can Pursue Class Action
- Xi Jinping Supports Hong Kong's Economic Strategies and Development
- Solar Alliance Energy Gains Shareholder Approval in Key Meeting
- Fruit Street Health Enhances Diabetes Prevention with Meals
- CNOOC Limited Partners with INEOS Energy in New Agreement
- Exciting Collaboration: Celebrate Japan's Fruit Culture
- Investors Urged to Act Before Deadline in Xiao-I Class Action
- Karma Sauce Applauds First We Feast's Bold New Direction
- Cassava Sciences Investors Encouraged to Act on Stock Losses
- Investors Warned of Upcoming Deadline in WM Technology Case
- Investors Urged to Act: Acadia Healthcare Class Action Deadline
- Aehr Test Systems Faces Class Action, Investors Urged to Act Soon
- Investors Alert: Upcoming Lead Plaintiff Motion Deadline for CUBI
- Legal Action Announced for Five9, Inc. Investors Following Stock Decline
- Legal Action Launched for Kyverna Therapeutics Investors
- Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
- Haloid Enhances Safety in Film Productions with Reviews
- Insights on the Growing Demand for Edible Coatings in Produce
- Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
- Legal Update: Toronto-Dominion Bank Securities Class Action
- Key Updates from Nasdaq on the Nasdaq-100 Index Changes
- TeraBox Revolutionizes File Sharing with Free Unlimited Service
- Kessler Topaz Takes Action Against Enphase Energy for Fraud
- Demesne Resources Completes Second Tranche of Financing
- Spiro Celebrated as One of the Top Agencies in Marketing
- Global Uranium Corp. Launches Strategic Marketing Efforts
- UnitedHealth Group Clarifies Misconceptions and Updates Claims
- Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
- Acadia Healthcare Investors Urged to Take Action on Lawsuit
- Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
- Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
- Hola Prime's Innovative Vision: New Marketing Director Appointed
- Teamsters Advocate for Stronger Standards on Autonomous Vehicles
- BioVaxys Secures Funding and Enters Debt Settlement Agreement